The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call
2 Cash-Heavy Stocks on Our Watchlist and 1 We Avoid
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at...
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance
Progyny’s (NASDAQ:PGNY) Q2 CY2026: Beats On Revenue But Stock Drops 10.2%
Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDA Robust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building Solutions Value Returned to Shareholders...
Barchart Research What to Expect from PGNY Earnings PGNY Generated August 5, 2026 Current Price $31.37 EPS Estimate $$0.28 Consensus Rating Strong Buy Average Move 14.80% Progyny's Q2 Report: Whether Revenue...